content top

Intravitreal Bevacizumab (AvastinĀ®) for Primary Treatment of Neovascular AMD

http://www.evrs.eu/medias/2006/congress/Intravitreal-Bevacizumab-(Avastin)-for-Primary-Treatment-of-Neovascular-AMD.swf David F. Williams, MD, MBA (Minneapolis, MN), Steven R. Bennett, MD (Minneapolis, MN), Herbert L. Cantrill, MD (Minneapolis, MN), Jill B. Johnson, MD (Minneapolis, MN), Robert A. Mittra, MD (Minneapolis, MN), Robert C. Ramsay, MD (Minneapolis, MN), Edwin H. Ryan, MD (Minneapolis, MN), Sundeep Dev, MD (Minneapolis,...

Read More

Intravitreal Bevacizumab for the Treatment of Choroidal Neovascularization Secondary to Ocular Histoplasmosis and Multifocal Choroiditis

http://www.evrs.eu/medias/2006/congress/Intravitreal-Bevacizumab-for-the-Treatment-of-Choroidal-Neovascularization-Secondary-to-Ocular-Histoplasmosis-and-Multifocal-Choroiditis.swf Sundeep Dev, MD (Minneapolis, MN) PURPOSE: To evaluate the visual outcomes and complications of intravitreal bevacizumab for the management of choroidal neovascularization (CNV) secondary to ocular histoplasmosis (OHS) and multifocal choroiditis (MFC). METHODS: A...

Read More
content top